BTMD vs TLRY
biote Corp. and Tilray Brands, Inc., side by side — 5 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | BTMD | TLRY |
|---|---|---|
| Revenue | $192.2M | $915.5M |
| Net income | $27.0M | $-121.4M |
| Gross margin | 71.5% | 28.4% |
| Net margin | 16.4% | −11.5% |
| Return on equity | — | −7.8% |
| Diluted EPS | $0.74 | −$1.09 |
| Dividend / share | — | — |
| Payout ratio | 6.4% | — |
| Free cash flow | $30.2M | — |
| Equity | $-58.5M | $1.6B |
| Net debt / equity | — | −0.13× |
| Current ratio | 1.22× | 2.21× |
| Revenue CAGR 5y | — | 12.3% |
| Profit CAGR 5y | — | — |
TLRY bills 4.8× the revenue of BTMD, and TLRY closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
5 years side by side
| Fiscal year | BTMD | TLRY |
|---|---|---|
| FY2025 | $192.2M | $915.5M |
| FY2024 | $197.2M | $821.3M |
| FY2023 | $185.4M | $788.9M |
| FY2022 | $165.0M | $627.1M |
| FY2021 | $139.4M | $628.4M |
Net income by year
Bottom line
| Fiscal year | BTMD | TLRY |
|---|---|---|
| FY2025 | $27.0M | $-121.4M |
| FY2024 | $3.2M | $-2.2B |
| FY2023 | $3.3M | $-245.0M |
| FY2022 | $-969,000 | $-1.5B |
| FY2021 | $32.6M | $-476.8M |
More in this industry